Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/17/24 → 1/17/27 |
Funding
- Quintiles, Inc. (Prot #1425-0003 // Prot #1425-0003)
- Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1425-0003 // Prot #1425-0003)
Prot #1425-0003: A Phase IIa, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BI 706321 Orally Administered for 12 Weeks in Patients with Crohn`s Disease (CD) Receiving Ustekinu
- Hanauer, stephen B (PD/PI)
Project: Research project